1. | socom7998 | |
2. | teamgrean | |
3. | 55intrigue24 | |
4. | oco4512 | |
5. | ash68th |
1. | socom7998 | |
2. | teamgrean | |
3. | 55intrigue24 | |
4. | oco4512 | |
5. | ash68th |
1. | 55intrigue24 03/15/2018 Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells |
2. | oco4512 03/15/2018 This floater is running |
3. | socom7998 01/08/2018 Breaking News: - Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 billion Target Cell Dose |
4. | ash68th 03/15/2018 Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update |
5. | socom7998 06/04/2018 Presented a safety update |
6. | socom7998 01/08/2018 Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company |
7. | 55intrigue24 03/15/2018 Great looking chart. Great data release.... combo here |